Literature DB >> 23903712

Impact of severe postoperative complications after cardiac surgery on mortality in patients aged over 80 years.

Hiroyuki Kamiya1, Nadine Tanzeem, Payam Akhyari, Anabel Pedraza, Klaus Kallenbach, Artur Lichtenberg, Matthias Karck.   

Abstract

BACKGROUND: The aims of this study are (1) to investigate the occurrence rate of postoperative complications in patients ≥ 80 years old after cardiac surgery and (2) to elucidate the impact of the most common postoperative complications on mortality.
METHODS: Between January 1998 and December 2007, 649 patients aged over 80 years received isolated first-time coronary artery bypass graft (CABG), isolated aortic valve replacement (AVR) or a combination of both in our institute. Prospectively entered patient data were analyzed with respect to major complications and outcome parameters.
RESULTS: Acute renal failure (55.0% vs. 7.5%, p = 0.0001), low cardiac out-put syndrome (43.1% vs. 8.8%, p = 0.0001), sepsis (52.0% vs. 10.3%, p = 0.0001), prolonged respiratory failure with tracheotomy (29.0% vs. 11.0%, p = 0.002), re-thoracotomy due to bleeding (26.9% vs. 10.6%, p = 0.0001), and postoperative laparotomy (30.8% vs. 11.5%, p = 0.033) had a significant impact on mortality. A multivariate analysis revealed that advanced age (OR 1.130, 95%CI; 1.017-1.256, p = 0.023), low output syndrome (OR 5.094, 95%CI; 1.1635-15.871, p = 0.005), renal failure (OR 8.128, 95%CI; 3.347-19.742, p = 0.0001) and sepsis (OR 4.975, 95%CI; 1.420-17.426, p = 0.012) as independent risk factors.
CONCLUSIONS: The present study demonstrates that among major complications, low output syndrome, renal failure requiring renal replacement therapy and sepsis, dramatically impaired the postoperative course patients aged over 80 years undergoing CABG, AVR or combined CABG and AVR.

Entities:  

Mesh:

Year:  2013        PMID: 23903712     DOI: 10.5761/atcs.oa.13-02268

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  6 in total

1.  Long-Term Outcome of Prosthetic Valve Replacement in Japanese Patients Aged 65 Years or Older: Are Guidelines for Prosthetic Valve Selection Based on Overseas Data Appropriate for Japanese Patients?

Authors:  Akira Sezai; Shunji Osaka; Hiroko Yaoita; Yusuke Ishii; Munehito Arimoto; Hiroaki Hata; Motomi Shiono
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-05-25       Impact factor: 1.520

2.  Early and Long-Term Outcomes in Japanese Patients Aged 80 Years or Older Undergoing Conventional Aortic Valve Replacement.

Authors:  Akira Sezai; Shunji Osaka; Hiroko Yaoita; Yusuke Ishii; Munehito Arimoto; Hiroaki Hata; Motomi Shiono
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-05-25       Impact factor: 1.520

3.  The efficacy and safety of dexmedetomidine in cardiac surgery patients: A systematic review and meta-analysis.

Authors:  Guobin Wang; Jianhua Niu; Zhitao Li; Haifeng Lv; Hongliu Cai
Journal:  PLoS One       Date:  2018-09-19       Impact factor: 3.240

4.  Do in-hospital outcomes of isolated coronary artery bypass grafting vary between male and female octogenarians?

Authors:  Rizwan Q Attia; Eve Katumalla; Shabnam Cyclewala; Melissa Rochon; Nandor Marczin; Shahzad G Raja
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-01

5.  The early and long-term outcomes of coronary artery bypass grafting added to aortic valve replacement compared to isolated aortic valve replacement in elderly patients: a systematic review and meta-analysis.

Authors:  Stefano D'Alessandro; Domenico Tuttolomondo; Gurmeet Singh; Daniel Hernandez-Vaquero; Claudia Pattuzzi; Alan Gallingani; Francesco Maestri; Francesco Nicolini; Francesco Formica
Journal:  Heart Vessels       Date:  2022-05-09       Impact factor: 1.814

Review 6.  Strategies for Pharmacological Organoprotection during Extracorporeal Circulation Targeting Ischemia-Reperfusion Injury.

Authors:  Aida Salameh; Stefan Dhein
Journal:  Front Pharmacol       Date:  2015-12-22       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.